On May 26, 2022, Philippines FDA opened the comment period for the draft of Updated Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2020-0017 (hereafter Guidelines) till June 2, 2022. The Guidelines shall take effect 15 days after its official publication.